Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects [Phase 2]
Phase 2 clinical trial evaluating [18F]APN-1607 PET uptake in Alzheimer's disease patients versus healthy subjects; status currently unknown…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer's Disease and Their Caregiver's [NA]
A completed clinical trial evaluating at-home telehealth yoga for chronic pain in people with Alzheimer disease and their caregivers; result…
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Apathy in Dementia Methylphenidate Trial 2 [Phase 3]
Phase 3 clinical trial on methylphenidate for apathy in Alzheimer's disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial update for ATH-1017 in mild to moderate Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study [Phase 2]
Phase 2a trial of SUVN-502 combined with donepezil and memantine for moderate Alzheimer's disease has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-06-07FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for donepezil hydrochloride from Macleods Pharmaceuticals Limited, enabling a regulatory change …
-
FDA approval · 2023-06-07FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride (generic) from Macleods Pharmaceuticals Limited.
-
FDA approval · 2023-06-07FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for memantine hydrochloride by Macleods Pharmaceuticals Limited, updating the approved drug prod…
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: Enhancing Consent for Alzheimer's Research [NA]
Clinical trial update on enhancing consent for Alzheimer's research; completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants. [Phase 4]
A Phase 4 pilot study evaluated methylphenidate in participants with Alzheimer dementia; results have been posted after completion.
-
CLINICAL_TRIALS research · 2023-06-02Clinical Trial Update: Care to Plan: a Tailored Resource for Family Members of Persons With Dementia [NA]
Clinical trial update for a resource supporting family members of persons with dementia; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180) [Phase 2]
A Phase 2 clinical trial update examining relationships between neuropsychological testing and imaging modalities in Alzheimer and Parkinson…
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Caring Light Project for Family Caregivers [Phase 2]
Phase 2 clinical trial update for Caring Light Project addressing Alzheimer's disease; trial completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Virtual Patient Behavioral Response Training for Family Caregivers [Phase 2]
Phase 2 trial update on a virtual patient behavioral response training program for family caregivers of Alzheimer disease patients; study co…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support: [NA]
Clinical trial completed for a WiFi-based localization system to support caregivers of dementia patients; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: [18F]MC225-PET in Neurodegenerative Disease [Phase 1, Phase 2]
Early-phase trial update for [18F]MC225-PET imaging in neurodegenerative diseases, including Alzheimer’s disease and related conditions (Pha…
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of Posiphen in subjects with early Alzheimer…
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy [Phase 2]
A Phase 2 clinical trial investigating the influence of vascular burden, amyloid plaque, and tau protein in patients with vascular cognitive…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease [Phase 2]
Phase 2 trial updating safety and potential efficacy of Trappsol Cyclo in patients with early Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease [Phase 2, Phase 3]
Phase 2/Phase 3 trial update on PM012 tablet for Alzheimer's disease assessing optimal dosage/administration.
-
CLINICAL_TRIALS withdrawal · 2023-04-14Clinical Trial Update: A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension [Phase 3]
Phase 3 MRCT of tricaprilin in mild to moderately severe probable Alzheimer's disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923 [Phase 1]
Phase 1 trial evaluating safety, tolerability, pharmacokinetics and receptor occupancy of BMS-984923 in Alzheimer's disease; results have be…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Environmental Design for Behavioral Regulation in People With Dementia [NA]
Clinical trial update for an environmental design approach aimed at behavioral regulation in people with dementia (Alzheimer's disease); stu…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway [EARLY_Phase 1]
Early-phase 1 trial assessing rapamycin's effect on the mTOR pathway in mild cognitive impairment and Alzheimer's disease has completed with…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial. [Phase 1, Phase 2]
Follow-up safety and efficacy study in subjects who completed the NEUROSTEM Phase I/IIa trial for Alzheimer's disease has been completed.